Radiocontrast interference in screening tests for genetic-metabolic diseases

Clinica Chimica Acta

Volumn 281, Issue 1-2, 1999, Pages 71-76

  Potter, Joseph L ^a   Timmons, G Dean ^a   Kofron, William G ^b  

^a AKRON CHILDREN'S HOSPITAL   (United States)

^b UNIVERSITY OF AKRON   (United States)

Author keywords

Genetic metabolic screening; Radiocontrast interference

Indexed keywords

AMINO ACID; CONTRAST MEDIUM; GLUTAMINE; GLYCINE; IOHEXOL; IOPAMIDOL; IOTALAMIC ACID; ISOLEUCINE; PURINE DERIVATIVE; PYRIMIDINE DERIVATIVE;

ARTICLE; COST; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; GENETIC DISORDER; HUMAN; MAJOR CLINICAL STUDY; METABOLIC DISORDER; PAPER CHROMATOGRAPHY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SCREENING TEST;

ARTIFACTS; CHROMATOGRAPHY, PAPER; CONTRAST MEDIA; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GENETIC SCREENING; HUMANS; METABOLISM, INBORN ERRORS; SPECTRUM ANALYSIS;

EID: 0033067608     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(98)00207-1     Document Type: Article

References (12)

1. Beaudet AL, Scriver CR, Sly WS, Valle D. Genetics, biochemistry, and molecular basis of variant human phenotypes. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic and molecular basis of inherited disease, 7th ed. New York: McGraw-Hill, 1995:97-102.
2. Erbe RW, Levy HL. Neonatal screening. In: Rimoin DL, Connor JM, Pyeritz RD, editors. Principles and practice of medical genetics, 3rd ed. New York: Churchill Livingstone, 1997:581-593.
3. Young DS. Effects of drugs on clinical laboratory tests, 3rd ed. Washington: AACC Press, 1990.
4. Young DS. Effects of drugs on clinical laboratory tests. Supplement to 3rd ed. Washington: AACC Press, 1991.
5. Timmons GD, Potter JL, Kofron WG Interferences in genetic neurological disease screening due to prior administration of neuroradiological contrast (Abstract). Ann Neurol. 30:1991;276.
6. Rossel RA, Coryell ME, Blankenship PR, Hall WK Interference by meglumine diatrizoate in screening for amino-acid disorders. Clin Chim Acta. 83:1978;293-294.
7. Broadwell DK, Beaudet AL Interference of radioopaque dye with the 2,4-dinitrophenylhydrazine test. J Pediatr. 89:1976;156.
8. Potter JL, Weinberg AG, West R Ampicillinuria and ampicillin crystalluria. Pediatrics. 48:1971;636-639.
9. Potter JL Further observations on ninhydrin-reacting compounds in urine. J Pediatr. 84:1984;250-251.
10. Tserng KY, Griffin RL, Kerr DS Distinction of dicarboxylic aciduria due to medium-chain triglyceride feeding from that due to abnormal fatty acid oxidation and fasting in children. Metabolism. 45:1996;162-167.
11. Schwert GW, Takenaka Y A spectrophotometric determination of trypsin and chymotrypsin. Biochim Biophys Acta. 16:1955;570-575.
12. McCaldin DJ The chemistry of ninhydrin. Chem Rev. 60:1960;39-51.